KIRREL3
Kin of IRRE-like protein 3
Also known as: KIAA1867, KIRR3_HUMAN, KIRRE, NEPH2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IZU9
- Gene
- KIRREL3
- Ensembl
- ENSG00000149571
- Chromosome
- 11
- Canonical length
- 778 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins
- Secretome location
- Intracellular and membrane
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is a member of the nephrin-like protein family. These proteins are expressed in fetal and adult brain, and also in podocytes of kidney glomeruli. The cytoplasmic domains of these proteins interact with the C-terminus of podocin, also expressed in the podocytes, cells involved in ensuring size- and charge-selective ultrafiltration. The protein encoded by this gene is a synaptic cell adhesion molecule with multiple extracellular immunoglobulin-like domains and a cytoplasmic PDZ domain-binding motif. Mutations in this gene are associated with several neurological and cognitive disorders. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2017]
Canonical amino-acid sequenceUniProt
778 residues, UniProt reviewed canonical sequence.
>Q8IZU9|KIRREL3
1 MKPFQLDLLF VCFFLFSQEL GLQKRGCCLV LGYMAKDKFR RMNEGQVYSF SQQPQDQVVV
61 SGQPVTLLCA IPEYDGFVLW IKDGLALGVG RDLSSYPQYL VVGNHLSGEH HLKILRAELQ
121 DDAVYECQAI QAAIRSRPAR LTVLVPPDDP VILGGPVISL RAGDPLNLTC HADNAKPAAS
181 IIWLRKGEVI NGATYSKTLL RDGKRESIVS TLFISPGDVE NGQSIVCRAT NKAIPGGKET
241 SVTIDIQHPP LVNLSVEPQP VLEDNVVTFH CSAKANPAVT QYRWAKRGQI IKEASGEVYR
301 TTVDYTYFSE PVSCEVTNAL GSTNLSRTVD VYFGPRMTTE PQSLLVDLGS DAIFSCAWTG
361 NPSLTIVWMK RGSGVVLSNE KTLTLKSVRQ EDAGKYVCRA VVPRVGAGER EVTLTVNGPP
421 IISSTQTQHA LHGEKGQIKC FIRSTPPPDR IAWSWKENVL ESGTSGRYTV ETISTEEGVI
481 STLTISNIVR ADFQTIYNCT AWNSFGSDTE IIRLKEQGSE MKSGAGLEAE SVPMAVIIGV
541 AVGAGVAFLV LMATIVAFCC ARSQRNLKGV VSAKNDIRVE IVHKEPASGR EGEEHSTIKQ
601 LMMDRGEFQQ DSVLKQLEVL KEEEKEFQNL KDPTNGYYSV NTFKEHHSTP TISLSSCQPD
661 LRPAGKQRVP TGMSFTNIYS TLSGQGRLYD YGQRFVLGMG SSSIELCERE FQRGSLSDSS
721 SFLDTQCDSS VSSSGKQDGY VQFDKASKAS ASSSHHSQSS SQNSDPSRPL QRRMQTHVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against KIRREL3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.45
- Highest tissue expression
- 27 nTPM
Expression across tissuesHPA
Tissue
- basal ganglia: 27 nTPM
- cerebral cortex: 18 nTPM
- hippocampal formation: 13 nTPM
- cerebellum: 12 nTPM
- spinal cord: 12 nTPM
- amygdala: 12 nTPM
Single-cell type
- oligodendrocytes: 989 nCPM
- brain inhibitory neurons: 767 nCPM
- brain excitatory neurons: 589 nCPM
- retinal amacrine cells: 551 nCPM
- late spermatids: 413 nCPM
- retinal bipolar cells: 347 nCPM
Immune cell
- plasmacytoid DC: 8.3 nTPM
- basophil: 0.6 nTPM
- neutrophil: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- basal ganglia: 53 nTPM
- amygdala: 44 nTPM
- white matter: 44 nTPM
- cerebral cortex: 42 nTPM
- thalamus: 41 nTPM
- midbrain: 40 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about KIRREL3.
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 184 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Intellectual disability, autosomal dominant 4
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.32
- gnomAD pLI
- 0.97
- gnomAD missense Z
- 2.35
- DepMap mean gene effect
- 0.15
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell-cell adhesion
- glomerulus morphogenesis
- hemopoiesis
- hippocampus development
- homophilic cell adhesion via plasma membrane adhesion molecules
- inter-male aggressive behavior
- neuron migration
- neuron projection morphogenesis
- principal sensory nucleus of trigeminal nerve development
- synapse assembly
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Immunoglobulin subtype 2
- Immunoglobulin domain subtype
- Immunoglobulin-like domain
- Immunoglobulin I-set
- CD80-like, immunoglobulin C2-set
- Immunoglobulin-like fold
- Immunoglobulin-like domain superfamily
- Cellular adhesion and signaling domain-containing protein
- Immunoglobulin I-set domain
- CD80-like C2-set immunoglobulin domain
- Immunoglobulin domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of KIRREL3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KIRREL3 as an antibody target. Whether an autoantibody or antibody against KIRREL3 could matter depends on whether native KIRREL3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KIRREL3 is annotated at the cell surface, where native KIRREL3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label KIRREL3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...